| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/17/2002 | CN1345238A Method for treatment of neurological or neuropsychiatric disorders |
| 04/17/2002 | CN1345237A Method for prevention or reduction of cariovascular events associated with coronary intervention |
| 04/17/2002 | CN1345189A Nutritional compositions with contain slightly negatively charged, non-digestible polysaccharides and use thereof for reducing transport through tight junctions |
| 04/17/2002 | CN1344715A Thenoyl piperazine derivative with positive myodyamia effect |
| 04/17/2002 | CN1344712A Synthesis path of Timisatem |
| 04/17/2002 | CN1344561A Medicine for treating various kinds of hemiplegia |
| 04/17/2002 | CN1344560A Medicine mainly for treating arthralgia and apoplexy sequelae |
| 04/17/2002 | CN1344551A Neurasthenia treating capsule |
| 04/17/2002 | CN1082963C Isoxazolidine derivatives |
| 04/17/2002 | CN1082961C Novel use and novel derivatives of imidazole, method for preparing same, novel intermediates thus obtained, medicinal and applications as medicine and pharmaceutical compositions thereof |
| 04/17/2002 | CN1082950C Quinoline derivatives containing diol as leukotriene antagonists |
| 04/17/2002 | CN1082948C 4-amino-1-piperidylbenzoylguanidine |
| 04/17/2002 | CN1082815C 吲哚衍生物 Indole derivatives |
| 04/16/2002 | US6372957 Transgenic mouse comprising a MEF2 binding site operatively linked to an indicator gene and methods of use |
| 04/16/2002 | US6372917 Inhibit cellular sodium ion-dependent chloride ion/bicarbonate-exchange mechanism or sodium/bicarbonate symporter; treatment of all acute or chronic damage caused by ischemia or illnesses induced thereby |
| 04/16/2002 | US6372783 Enantiomeric compounds for treatment of cardiac arrhythmias and methods of use |
| 04/16/2002 | US6372777 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/16/2002 | US6372776 Crystalline(−)-3R,4R-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-{4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}chromane, hydrogen maleate |
| 04/16/2002 | US6372768 2-aminopyridines containing fused ring substituents |
| 04/16/2002 | US6372763 Treatment and prevention of cardiac disorders using selective serotonin re-uptake inhibitors (SSRI) |
| 04/16/2002 | US6372759 Antithrombotic agents |
| 04/16/2002 | US6372758 Sulfamato hydroxamic acid metalloprotease inhibitor |
| 04/16/2002 | US6372756 Narcotics or analgesics |
| 04/16/2002 | US6372754 Drugs for treatment or prevention of depression, anxiety, pain, inflammation, migraine, emesis or postherpic neuralgia. |
| 04/16/2002 | US6372751 Drugs with benzene and pyrimidine rings |
| 04/16/2002 | US6372743 Certain alkylene diamine-substituted pyrazlo (1,5-a)-1,5-pyrimidines and pyrazolo (1,5-a) 1,3,5-triazines |
| 04/16/2002 | US6372741 Use of CSAID™ compounds as inhibitors of angiogenesis |
| 04/16/2002 | US6372723 Administering selective adenosine a2a receptor agonist and/or antagonist; occlusion removal; surgery; reroute blood flowthrough bypass graft |
| 04/16/2002 | US6372719 ανβ3 integrin antagonists in combination with chemotherapeutic agents |
| 04/16/2002 | US6372487 Polynucleotides encoding peptide release factor, prfC (RF-3), a GTP-binding protein |
| 04/16/2002 | US6372473 Tissue plasminogen activator-like protease |
| 04/16/2002 | US6372468 Useful in the development of human therapeutics and diagnostic formulations |
| 04/16/2002 | US6372462 Cultivating a fungi of the basidiomycetes in a submerged culture on nutrient media, isolating the biomass of edible mushrooms from the culture broth, and drying at a range of 40-45 degrees celsius |
| 04/16/2002 | US6372433 Antisense modulation of inhibitor of DNA binding-1 expression |
| 04/16/2002 | US6372267 Cocoa solids prepared by heating, pressing, recovering partially defatted cocoa solids which contain cocoa polyphenols including cocoa procyanidins |
| 04/16/2002 | US6372264 Method of reducing calcified arterial plaque buildup and cellular malfunction and for balancing ionic calcium |
| 04/16/2002 | US6372262 Serum-derived factor inducing cell differentiation and medical uses thereof |
| 04/16/2002 | US6372229 Curing water soluble proteinaceous material and di- or polyaldehyde |
| 04/16/2002 | CA2260413C Terpenoid lactone compounds and their production process |
| 04/11/2002 | WO2002029090A1 Subsance inhibiting the binding of signal transducing molecule to kdr/flk-1 phosphorylated at tyrosine at the 1175-position and method of using the same |
| 04/11/2002 | WO2002029088A2 Highly expressible genes |
| 04/11/2002 | WO2002029061A2 G-protein coupled receptors |
| 04/11/2002 | WO2002029058A2 Human proteins, polynucleotides encoding them and methods of using the same |
| 04/11/2002 | WO2002029055A2 Carbohydrate-associated proteins |
| 04/11/2002 | WO2002029053A1 Novel g protein-coupled receptor protein and dna thereof |
| 04/11/2002 | WO2002029044A2 Modulation of the transcription of pro-inflammatory gene products |
| 04/11/2002 | WO2002029038A2 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
| 04/11/2002 | WO2002029036A2 Lipid metabolism enzymes |
| 04/11/2002 | WO2002029031A2 Isoprenoid-dependent ras anchorage (idra) proteins |
| 04/11/2002 | WO2002028902A2 Nectin polypeptides, polynucleotides, methods of making and use thereof |
| 04/11/2002 | WO2002028895A2 Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator |
| 04/11/2002 | WO2002028885A1 N-alkylglycine trimeres capable of protecting neurons against excitotoxic aggressions and compositions containing said trimeres |
| 04/11/2002 | WO2002028880A2 Compounds useful for treating hypertriglyceridemia |
| 04/11/2002 | WO2002028867A2 Ethers of 7-desmethylrapamycin for use in immunosuppression |
| 04/11/2002 | WO2002028866A2 Hydroxyesters of 7-desmethylrapamycin |
| 04/11/2002 | WO2002028865A2 Condensed pyridoindole derivatives |
| 04/11/2002 | WO2002028864A1 New process for the production of oxabispidines |
| 04/11/2002 | WO2002028863A1 New oxabispidine compound useful in the treatment of cardiac arrhythmias |
| 04/11/2002 | WO2002028859A2 Condensed pyridoindole derivatives |
| 04/11/2002 | WO2002028858A2 Hexahydropyrazino `1'2' : 1, 6!- pyrido `3, 4-b! indole-1, 4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction |
| 04/11/2002 | WO2002028856A1 Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases |
| 04/11/2002 | WO2002028853A1 Benzylamine compound, process for producing the same, and intermediate therefor |
| 04/11/2002 | WO2002028845A1 3-thioxo-[1,2,4]-oxadiazinan-5-one and their use as anti-antherosclerotic agents |
| 04/11/2002 | WO2002028837A1 Metabotropic glutamate receptor antagonists |
| 04/11/2002 | WO2002028836A1 Novel crystalline forms of a factor xa inhibitor |
| 04/11/2002 | WO2002028835A1 Benzamide compounds as apo b secretion inhibitors |
| 04/11/2002 | WO2002028831A1 Inhibitors of prenyl-protein transferase |
| 04/11/2002 | WO2002028830A1 Novel phenylalanine derivatives |
| 04/11/2002 | WO2002028828A1 Substituted (e)-styryl benzylsulfones for treating proliferative disorders |
| 04/11/2002 | WO2002028827A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation |
| 04/11/2002 | WO2002028825A2 Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors |
| 04/11/2002 | WO2002028820A1 Nitroso diphenylamine derivatives |
| 04/11/2002 | WO2002028434A2 Use of a ppar delta activator for treating inflammatory conditions |
| 04/11/2002 | WO2002028433A2 Use of a ppar delta activator in the treatment of diseases related to no inhibit ion or tnf inhibition |
| 04/11/2002 | WO2002028406A2 Induction of blood vessel formation by polynucleotides encoding sphingosine kinases |
| 04/11/2002 | WO2002028395A1 Phosphoric acid salt of an integrin receptor antagonist |
| 04/11/2002 | WO2002028392A1 Remedies for brain circulatory disturbances |
| 04/11/2002 | WO2002028390A1 Composition comprising a catalyst for the dismutation of superoxide and use of the composition for preventing and treating hypotension |
| 04/11/2002 | WO2002028388A2 Use of mek1 inhibitors as protective agents against damage due to ischemia |
| 04/11/2002 | WO2002028377A1 Ihnalation particles incorporating a combination of two or more active ingredients |
| 04/11/2002 | WO2002028376A2 Chrono delivery formulations and method of use thereof |
| 04/11/2002 | WO2002028355A2 Methods and compositions for enhancing angiogenesis |
| 04/11/2002 | WO2002028349A2 Method of treating cancer using dithiocarbamate derivatives |
| 04/11/2002 | WO2002028347A2 Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them |
| 04/11/2002 | WO2002028165A2 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 04/11/2002 | WO2002006300A3 Mutated pf-4, its fragments and mutated fusion peptides, their analogues, corresponding dna, cdna and mrna sequences and their use for inhibiting angiogenesis |
| 04/11/2002 | WO2002000725A3 G-protein coupled receptor org10 |
| 04/11/2002 | WO2001094279A3 Purification of xanthophylls from marigold extracts that contain high levels of chlorophylls |
| 04/11/2002 | WO2001092308A3 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 04/11/2002 | WO2001090070A3 Caspase inhibitors and uses thereof |
| 04/11/2002 | WO2001090069B1 Novel calcium receptor active molecules and method for preparing same |
| 04/11/2002 | WO2001087342A3 Delivery devices for treatment of vascular disease |
| 04/11/2002 | WO2001085671A3 Anthranyl amides and their use as medicaments |
| 04/11/2002 | WO2001084962A3 Compositions containing folic acid and reduced folate |
| 04/11/2002 | WO2001083450A3 (2-oxindol-3-ylidenyl)acetic acid derivatives and their use as protein kinase inhibitors |
| 04/11/2002 | WO2001077079A3 Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade |
| 04/11/2002 | WO2001076572A3 Use of compatible solutes as substances having free radical scavenging properties |
| 04/11/2002 | WO2001074856A3 Wnt-7b-like polypeptides and nucleic acids encoding same |
| 04/11/2002 | WO2001070174A3 Vegf-modulated genes and methods employing them |
| 04/11/2002 | WO2001059153A3 Method for identifying substances which modulate the activity of hyperpolarisation-activated cation channels |